SCHEMBL16449274

SCHEMBL16449274

COC(=O)c1ccc(Nc2nc(NCCOCCOCCNC(=O)c3ccccc3)nc(Nc3ccccc3)n2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12832766 0.95
SCHEMBL16449254 0.92
SCHEMBL16449276 0.90
SCHEMBL12833059 0.90
SCHEMBL12833039 0.90 KCNH3 (0.67)
SCHEMBL12832774 0.89
SCHEMBL16449004 0.88
SCHEMBL12833040 0.88
SCHEMBL16361212 0.88
SCHEMBL14386048 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9603852-B2 Treatment of obesity and pulmonary arterial hypertension ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2017-03-28 US disclosed
EP-2488032-B1 PROSTAGLANDIN TRANSPORTER INHIBITORS AND USES THEREOF EINSTEIN COLL MED (US) 2016-11-02 EP disclosed
US-20160113933-A1 TREATMENT OF OBESITY AND PULMONARY ARTERIAL HYPERTENSION ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2016-04-28 US disclosed
US-8952150-B2 Prostaglandin transporter inhibitors and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2015-02-10 US disclosed